Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-12-17-Speech-2-279"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-12-17"^^xsd:date2
dcterms:Is Part Of	lp_eu:Human blood and blood components2
dcterms:Language	"fi"^^xsd:language2
lpv:document identification number	"en.20021217.8.2-279"2
lpv:hasSubsequent	lp_eu:2002-12-17-Speech-2-2802
lpv:speaker	lp:Eija-Riitta Korhola2
lpv:spokenAs	member; EPP-ED (1999-07-20--2004-07-19)3 unknown; Suomen kristillisdemokraatit rp (2001-05-30--2004-07-19)3 member; Delegation to the EU-Latvia Joint Parliamentary Committee (2002-02-07--2004-04-30)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 substitute; Committee on Foreign Affairs, Human Rights, Common Security and Defence Policy (2002-01-17--2004-07-19)3
lpv:translated text	"Madam President, I would like to congratulate my colleague, Mr Nisticó, for the outcome of conciliation, which must be considered a good achievement from Parliament’s viewpoint. Many of our aims were realised, and the directive must surely serve to contribute to general confidence both in the quality of donated blood and in the health protection of donors in an integrating Europe. For Finns the end result will not, however, be spot on, as it were. Parliament accepted my amendment regarding the non-remuneration of blood donation in the first reading in September 2001, but we had to yield in the end. We would have been very glad to see an unconditional principle of non-remuneration applied throughout Europe; now it is mentioned merely as a hoped-for goal, and not, unfortunately, as an obligation. In the actual Article that concerns non-remuneration the hope is expressed that blood and blood components should be derived as far as possible from this type of donation. The non-remuneration principle was resisted with the argument that it was hard to obtain rare blood products. I myself would have resolved the matter in individual cases without opening the floodgates to remuneration for all blood products. Many patient groups and authorities at one time appealed to Parliament not to allow the commercialisation of blood donation. First of all, there is a safety risk involved. There is also an ethical risk. We have a responsibility for the extent to which the rest of the world copies what we do. If we allow trade in human body parts and blood we have to consider that the less developed countries will follow Europe’s example. This could lead not only to exploitation but increased risk. Furthermore, several Member States are signatories to a bioethical agreement which categorically forbids the economic exploitation of the human body and its parts, including blood. Finland does not, however, need to renounce its principle of non-remuneration, as the recitals refer to the rights of Member States to maintain stricter protective measures by virtue of the Treaty. I hope that when in time this directive is reviewed, we will also consider the part the principle of non-remuneration has to play."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph